Government of Iraq   Report issue

Government Phase 2 Phase 3
Founded: Baghdad Iraq (2005)

Organization Overview

First Clinical Trial
2011
NCT03361618
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Directorate of health of Sulaimani, Iraq -KRG | Ministry of Health, Iraq | Ministry Of Health / Nineveh Health Directorate

Active Ingredients

Drugs in Phase 3 Trials (2)

diphenhydramine (benadryl) (1 trial)

nefopam (Acupan) (1 trial)

Drugs in Phase 2 Trials (2)

xagrotin (1 trial)

zinc dichloride (2 trials)

Drugs in Other Trials (1)

zinc sulfate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthenozoospermia (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 5